Speaker Profile
M.D., Executive Vice President and Chief Technology Officer, Amgen
Biography
David Reese oversees Amgen's Digital and Technology Innovation, the Office of the Chief Medical Officer, and the development and deployment of artificial intelligence across the enterprise. Reese joined Amgen in 2005 and previously served in various leadership roles within the Research and Development organization. This includes most recently functioning as executive vice president of Research and Development, where he oversaw Amgens worldwide research efforts and the advancement of Amgens pipeline in all therapeutic areas.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair:
- William Oh, Mount Sinai
Patient-centric data – Real-World Evidence (RWE) and Real-World Data (RWD) - is becoming instrumental in the drug development process and for health care decisions in general. This data is not only informative for the process from discovery to new indications, clinical trial design, and drug development, it also can be of value to monitor post-marketing drug safety and for decision support in clinical practice. As the data becomes a decision driver, science companies and medical organizations are increasingly focused on leveraging RWD and RWE to not only better understand the patient populations using their drugs and the respective outcomes, but also to accelerate clinical decision support. This session will focus on the various aspects of integrating RWE and RWD to support drug development and clinical decision support.
Sessions:
- PMWC 2025 Award Ceremony
Pioneer Honoree: Isaac Kohane, Harvard
- Keynote: Can AI succeed where humans have failed to personalize medicine?
- Isaac Kohane, Harvard
- From Data to Decisions: Real-Time Patient Insights for Improved Care
Chair: Michael Pfeffer, Stanford Medicine
- Chris Longhurst, UC San Diego Health
- Tanya Townsend, Stanford Children’s
- Kiran Mysore, Sutter Health
- Cherodeep Goswami, UW Health - Data Privacy and Security (and Health Equity) Challenges to the Use of Health Data in AI
Chair: Deven McGraw, Invitae
- Accelerating Drug Development with Real World Evidence and AI: Amgen's Journey
- David M. Reese, Amgen
